Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHELATE Study: TETA 4HCl vs Penicillamine in Wilson's Disease
NCT03539952Phase 3Completed
- Sponsor
- Orphalan
- Start
- Sep 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of trientine in Wilson disease (WD), sponsored by Orphalan. Started Sep 2018; status: completed.
02
Drugs
trientine
03
Conditions
Wilson disease (WD)
Beyond the preview
Go deeper on NCT03539952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03539952.